Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

The relation between plasma levels of nesfatin-1 and different grades of diabetic kidney disease in patients with type 2 diabetes

The Egyptian Journal of Internal Medicine volume 30, pages 68–71 (2018)Cite this article

Abstract

Background

Diabetic kidney disease (DKD) is the leading cause of renal failure. Diabetic patients with microalbuminuria typically progress to proteinuria and overt diabetic nephropathy. Nesfatin-1 is an anoretic polypeptide with potent metabolic regulatory effects and its circulating levels are shown to be elevated in type 2 diabetes mellitus (T2 DM).

Nesfatin-1 may be involved in the pathogenesis of DKD through inflammatory mechanisms.

The aim of the work was to study the relation between plasma nesfatin-1 levels and different grades of DKD in patients with T2 DM.

Patients and methods

This study was conducted on 120 patients with T2 DM and 20 controls selected from the inpatient department and outpatient clinics of the Internal Medicine Department in Menoufia University Hospital. The selected individuals were grouped into four groups: group1 included 20 healthy individuals, group 2 included 40 patients with T2DM with normoalbuminuria, group 3 included 40 patients with T2 DM with microalbuminuria, and group 4 included 40 patients with T2 DM with macroalbuminuria.

Members of the study were subjected to thorough history with special emphasis on age, sex, and duration of the DM. Investigations included fasting blood glucose, glycosylated hemoglobin, complete urine analysis, serum creatinine, urine albumin–creatinine ratio, estimated glomerular filtration rate, and plasma nesfatin-1.

Results

Plasma nesfatin-1 was significantly higher in group 4 compared with other groups, in group 3 compared with groups 1 and 2, and in group 2 compared with group 1. There was a positive significant correlation between plasma nesfatin-1 and serum creatinine, urine albumin–creatinine ratio, and glycosylated hemoglobin and negative significant correlation between plasma nesfatin-1 and estimated glomerular filtration rate in the studied diabetic patients. There was no correlation between plasma nesfatin-1 and BMI and duration of diabetes in the diabetic patients.

Conclusion

From this study, we can conclude that plasma nesfatin-1 is significantly higher in patients with DKD, and there is a positive correlation between plasma nefatin-1 level and the grades of DKD. So, plasma nesfatin-1 may be considered for prediction of developing DKD in a previously unaffected patients with DM.

References

  1. Oh-I S, Shimizu H, Satoh T. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443:709–712.

    Article  Google Scholar 

  2. Abaci A, Catli G, Anik A, Kume T, Bober E. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diab 2013; 14:189–195.

    CAS  Google Scholar 

  3. Pan W, Hsuchou H, Kastin AJ. Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides 2007; 28:2223–2228.

    Article  CAS  Google Scholar 

  4. Dong J, Xu H, Xu H, Wang PF, Cai GJ, Song HF. Nesfatin-1 stimulates fatty-acid oxidation by activating AMP-activated protein kinase in STZ-induced type 2 diabetic mice. PLoS One 2013; 8:833–863.

    Article  Google Scholar 

  5. Wu D, Yan M, Chen Y, Jia Y, Ma ZA, Boden G, et al. Hypothalamic nesfatin-1/NUCB2 knockdown augments hepatic gluconeogenesis that is correlated with inhibition of mTOR-STAT3 signaling pathway in rats. Diabetes 2014; 63:1234–1247.

    Article  CAS  Google Scholar 

  6. Aydin S. Multi-functional peptide hormone NUCB2/nesfatin-1. Endocrine 2013; 44:312–325.

    Article  CAS  Google Scholar 

  7. Aslan M, Celik O, Celik N, Turkcuoglu I, Yilmaz E, Karaer A, et al. Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 2012; 41:424–429.

    Article  CAS  Google Scholar 

  8. Tuttle KR, Bakris GL, Bilous JL, Chiang H, Boer J, Goldstein F, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis 2014; 64:510–533.

    Article  Google Scholar 

  9. Kathrine MD. The evaluation of diabetic nephropathy: preventing complications. Am J Kidney Dis 2002; 39:s1–s46.

    Google Scholar 

  10. Lewis J, Agodoa L, Cheek D, Greene T, Middleton J, O’Connor D, et al. Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate. Am J Kidney Dis 2001; 38: 744–753.

    Article  CAS  Google Scholar 

  11. The University of Oxford. HOMA calculator; 2016. Available at: https://www.dtu.ox.ac.uk/homacalculator/. [Accessed 8 October 2016]

  12. Zhang Z, Li L, Yang G, Liu G, Boden G, Yang M, et al. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diab 2012; 120:91–95.

    Article  CAS  Google Scholar 

  13. Li Q, Wang Y, Chen X, Guan Z, Jiang Y. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 2010; 159: 72–77.

    Article  CAS  Google Scholar 

  14. Jiang G, Wang M, Wang L, Chen H, Chen Z, Guo J, et al. The protective effect of nesfatin-1 against renal ischemia-reperfusion injury in rats. Ren Fail 2014; 37:882–889.

    Article  Google Scholar 

  15. Özsavcí D, Erşahin M, Sener A, Özakpinar ÖB, Toklu HZ, Akakín D, et al. The Novel Function of nesfatin-1as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery 2011; 68:1699–1708.

    Article  Google Scholar 

  16. Anwar GM, Yamamah G, Ibrahim A, El-Lebedy D, Farid TM, Mahmoud R, et al. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance. Regul Pept 2014; 188:21–24.

    Article  CAS  Google Scholar 

  17. Prinz P, Goebel-Stengel M, Teuffel P, Rose M, Klapp BF, Stengel A, et al. Peripheral and central localization of the nesfatin-1 receptor using autoradiography in rats. Biochem Biophys Res Commun 2016; 470: 521–527.

    Article  CAS  Google Scholar 

  18. Qi C, Ma H, Zhang HT, Gao JD, Xu Y. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma. Histopathology 2016; 66:650–657.

    Article  Google Scholar 

  19. Ademoglu EN, Gorar S, Carlıoglu A, Yazıcı H, Dellal FD, Berberoglu Z, et al. Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome. J Endocrinol Invest 2014; 37: 715–719.

    Article  CAS  Google Scholar 

  20. Liu F, Yang Q, Gao N, Liu S, Shen F. Decreased plasma nesfatin-1 level is related to the thyroid dysfunction in patients with type 2 diabetes mellitus. J Diab Res 2014; 67:1739–1742.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Menoufia University, Shebeen El-Kom, Egypt

    Mohamed A. Korani (Assistant Professor)

  2. Department of Clinical Pathology, Menoufia University, Shebeen El-Kom, Egypt

    Ahmed Sonbol

Authors
  1. Mohamed A. Korani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmed Sonbol
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Korani, M.A., Sonbol, A. The relation between plasma levels of nesfatin-1 and different grades of diabetic kidney disease in patients with type 2 diabetes. Egypt J Intern Med 30, 68–71 (2018). https://doi.org/10.4103/ejim.ejim_82_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_82_17

Keywords